The management of herpes simplex infections remains a significant concern in modern medicine. Innovations in treatment offer improved outcomes for patients. One such advancement is the use of acyclovir cream at a concentration of 5%. This topical agent provides targeted…

Nimustine, a key chemotherapeutic agent, has shown promise in glioblastoma management. This high-grade brain tumor remains a challenge. Treatment options often fall short, but nimustine’s alkylating properties offer hope. Glioblastoma’s aggressive nature requires effective interventions. Patients face limited survival. Nimustine’s…